Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-ACOX2 antibody (270-350 aa) (STJ190504) | Login | Anti-ACOX2 antibody (270-350 aa) (STJ190504) | ||||||||||||||||
|
||||||||||||||||||
Anti-ADAM9 antibody (120-200 aa) (STJ190515) | Login | Anti-ADAM9 antibody (120-200 aa) (STJ190515) | ||||||||||||||||
|
||||||||||||||||||
Anti-KRT35 antibody (340-420 aa) (STJ190351) | Login | Anti-KRT35 antibody (340-420 aa) (STJ190351) | ||||||||||||||||
|
||||||||||||||||||
Anti-ALDH1A3 antibody (290-370 aa) (STJ190531) | Login | Anti-ALDH1A3 antibody (290-370 aa) (STJ190531) | ||||||||||||||||
|
||||||||||||||||||
Anti-AKR1C4 antibody (1-80 aa) (STJ190533) | Login | Anti-AKR1C4 antibody (1-80 aa) (STJ190533) | ||||||||||||||||
|
||||||||||||||||||
Anti-CANX antibody (550aa C-Term) (STJ140017) | Login | Anti-CANX antibody (550aa C-Term) (STJ140017) | ||||||||||||||||
|
||||||||||||||||||
Anti-CTSD antibody (275aa C-Term) (STJ140018) | Login | Anti-CTSD antibody (275aa C-Term) (STJ140018) | ||||||||||||||||
|
||||||||||||||||||
Anti-CTNNB1 antibody (731aa C-Term) (STJ140021) | Login | Anti-CTNNB1 antibody (731aa C-Term) (STJ140021) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD4 antibody (50-235aa ECD) (STJ140023) | Login | Anti-CD4 antibody (50-235aa ECD) (STJ140023) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD19 antibody (510aa C-Term) (STJ140024) | Login | Anti-CD19 antibody (510aa C-Term) (STJ140024) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD19 antibody (510aa C-Term) (STJ140025) | Login | Anti-CD19 antibody (510aa C-Term) (STJ140025) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTPRC antibody (1260aa C-Term) (STJ140026) | Login | Anti-PTPRC antibody (1260aa C-Term) (STJ140026) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDH2 antibody (850aa to C-Term) (STJ140028) | Login | Anti-CDH2 antibody (850aa to C-Term) (STJ140028) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD63 antibody (120aa to 175aa) (STJ140029) | Login | Anti-CD63 antibody (120aa to 175aa) (STJ140029) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDIA3 antibody (300aa C-Term) (STJ140035) | Login | Anti-PDIA3 antibody (300aa C-Term) (STJ140035) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDIA3 antibody (300aa C-Term) (STJ140036) | Login | Anti-PDIA3 antibody (300aa C-Term) (STJ140036) | ||||||||||||||||
|
||||||||||||||||||
Anti-GAPDH antibody (240aa C-Term) (STJ140037) | Login | Anti-GAPDH antibody (240aa C-Term) (STJ140037) | ||||||||||||||||
|
||||||||||||||||||
Anti-Chaperonin GroEL protein antibody (400aa C-Term) (STJ140039) | Login | Anti-Chaperonin GroEL protein antibody (400aa C-Term) (STJ140039) | ||||||||||||||||
|
||||||||||||||||||
Anti-HIF1A antibody (780aa C-Term) (STJ140040) | Login | Anti-HIF1A antibody (780aa C-Term) (STJ140040) | ||||||||||||||||
|
||||||||||||||||||
Anti-MUTYH antibody (476aa C-Term) (STJ140046) | Login | Anti-MUTYH antibody (476aa C-Term) (STJ140046) | ||||||||||||||||
|
||||||||||||||||||
Anti-TP53 antibody (280aa C-Term) (STJ140047) | Login | Anti-TP53 antibody (280aa C-Term) (STJ140047) | ||||||||||||||||
|
||||||||||||||||||
Anti-TLR2 antibody (736aa C-Term) (STJ140050) | Login | Anti-TLR2 antibody (736aa C-Term) (STJ140050) | ||||||||||||||||
|
||||||||||||||||||
Anti-VEGFA antibody (STJ140053) | Login | Anti-VEGFA antibody (STJ140053) | ||||||||||||||||
|
||||||||||||||||||
Anti-KDR antibody (20-125aa) (STJ140092) | Login | Anti-KDR antibody (20-125aa) (STJ140092) | ||||||||||||||||
|
||||||||||||||||||
Anti-FZR1 antibody (601 to 701) (STJ140099) | Login | Anti-FZR1 antibody (601 to 701) (STJ140099) | ||||||||||||||||
|